Biointerface Technologies, Inc

Basic Information

1202 Ann Street
Madison, WI, 53713

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. NON-PROTEIN MR CONTRAST AGENT FOR BREAST CANCER IMAGING

    Amount: $49,492.00

    BREAST CANCER IS THE MOST COMMON MALIGNANCY IN WOMEN. FOR CANCER DIAGNOSIS, THE SEARCH FOR CONCEALED METASTASES IS THE SINGLE MOST IMPORTANT FACTOR IN THE TREATMENT DECISION FOR ALL CANCER PATIENTS. E ...

    SBIR Phase I 1991 Department of Health and Human Services
  2. ENZYME-BASED ANTISEPTIC WOUND DRESSING

    Amount: $50,000.00

    TOPICAL ANTIBACTERIAL AGENTS ARE WIDELY USED ON BURN WOUNDS IN AN OFTEN UNSUCCESSFUL ATTEMPT TO PREVENT/TREAT INFECTION.APPLICATION OF THESE ANTIMICROBIAL AGENTS REQUIRES THE REMOVAL OF THE SYNTHETIC ...

    SBIR Phase I 1988 Department of Health and Human Services
  3. ENZYME BASED ANTISEPTIC WOUND DRESSING

    Amount: $50,000.00

    TOPICAL ANTIBACTERIAL AGENTS ARE WIDELY USED ON BURN WOULDS IN AN OFTEN UNSUCCESSFUL ATTEMPT TO PREVENT/TREAT INFECTION. APPLICATIONS OF THESE ANTIMICROBIAL AGENTS REQUIRES THE REMOVAL OF THE SYNTHETI ...

    SBIR Phase I 1988 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government